Theoretical and practical limitations have prevented the measurement of regional cerebral blood flow using dynamic x-ray computed tomography. Development of the ultrafast computed tomography scanner has made it possible to overcome the practical limitations and measure changes in contrast concentration in the brain with excellent time and spatial resolution. By applying modifications of indicator dilution theory, we have derived a method to use these changes in contrast concentration determined using ultrafast computed tomography to measure the fractional vascular volume, mean transit time of blood, and blood flow within specific regions of the brain in a relatively simple and practical manner. This method could theoretically be used in the evaluation of physiological and pathophysiological alterations in cerebral blood flow. (Stroke 1991^2:768-771) M easurement of regional cerebral blood flow (rCBF) is useful in assessing the cerebrovascular response under normal, altered, and pathophysiological conditions. Dynamic computed tomography (CT) could be used for measuring rCBF noninvasively with high spatial resolution.
M easurement of regional cerebral blood flow (rCBF) is useful in assessing the cerebrovascular response under normal, altered, and pathophysiological conditions. Dynamic computed tomography (CT) could be used for measuring rCBF noninvasively with high spatial resolution. 1 -4 This technique consists of a series of CT images obtained during the passage of a bolus of iodinated contrast agent through the brain. Changes in contrast concentration as a function of time can be determined from the CT images, and rCBF-related information can be derived from these changes based on indicator dilution theory. The long period of time needed to acquire each CT scan and interscan delay times of >1.5 seconds hampered early attempts to use this technique. 3 - 5 The long acquisition and interscan delay times resulted in CT data from which the true indicator concentration could only be estimated, and then only at a few time points. The development of an ultrafast CT scanner, with an acquisition time of 50-100 msec and an interscan delay time of 0.6 seconds, has reduced the restrictions imposed by previous CT scanners. 6 Nevertheless, the development of an accurate means for estimating rCBF from a rapid sequence of CT images has not been established. Axel 1 proposed a dynamic CT method for assessing rCBF that was based on the estimation of fractional vascular volume and mean transit time of blood in specified regions of interest (ROIs) in the brain. However, differences between the peripheral and tissue hematocrit, which could affect the determination of fractional vascular volume, were not considered. Moreover, the determination of mean transit time depended on techniques that are difficult to implement, such as deconvolution of concentration versus time data from the ROI or identification and collection of time-concentration data of the supplying artery and draining vein for the ROI.
1 ' 7 -8 To avoid such difficulties, it was speculated that the center of gravity of time-concentration curves from an ROI might be used to calculate directly mean transit time, but the method for doing this was not derived. 1 In addition, it has been suggested that increased permeability of the bloodbrain barrier (BBB) could make rCBF values determined using dynamic CT erroneous, 9 but the magnitudes of the possible errors have not been determined.
The goal of this paper was to derive a theoretical and practical method of using dynamic CT to quantify rCBF in both normal and pathological tissue. The approach was based on an expansion and refinement of Axel's method and involved the use of indicator dilution techniques. The advantages and limitations of this method are discussed. Theory The noninvasive determination of rCBF based on indicator dilution theory depends on the accurate measurement of indicator concentration as a function of time after injection. In dynamic CT, the indicator is iodinated contrast medium, and changes in tissue CT number after the administration of contrast are linearly related to the actual concentration of contrast medium.
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6 Thus, the change in CT number versus time data obtained from a dynamic CT study directly corresponds to the concentration versus time data. Parameters relating to blood flow, including the center of gravity and the area under the curve, can be derived from the time-concentration data, 6 -1011 and these parameters can then be analyzed using indicator dilution principles to determine rCBF as demonstrated below ( Figure 1 ).
The rCBF can be calculated using the formula rCBF=VB/(t f ) (1) where V B represents the fractional blood volume and (tj) represents the mean transit time. 1 Because V B and (t f ) cannot be extracted directly from timeconcentration curves, it is necessary to use parameters from those curves to calculate them. The relation between tissue ROI and plasma (P) concentrations (C) at time t is C ROI (t)=V P xC P (t), where V P is the fractional volume of the ROI occupied by plasma. The total amount (A) of contrast delivered into an ROI by an arterial plasma concentration of C tf (t) and a constant plasma flow of F P is given by
V B can be derived by substituting the relations V P =V B (l-Hct R o,), C lP (t) = C,(t)/(l-Hct PA ), and Hct RO i=jxHct PA into Equation 2, so that
where C,(t) is the arterial blood iodine concentration, Hct is the hematocrit, PA represents a peripheral artery, and j is a proportionality constant relating peripheral hematocrit to tissue hematocrit. 12 Equation 3 can also be expressed in terms of the area under the time-concentration curve (AUC) as
Because AUC following a single contrast bolus should be the same for all arteries in the body, 1 any artery visible on a CT scan can potentially be used for the determination of AUC PA .
The value of (tf) is derived from the center of gravity of the time-concentration curve of the ROI, (t RO i), in the following manner. The CT number versus time function can be represented by the summation of a number of functions, f,{t), each representing the change in CT number due to the entrance of the ith molecule of contrast into the ROI. If the bolus instantaneously enters at time 0, each of the r contrast molecules will produce an equivalent change in CT number between times 0 and %, the transit time through the ROI for the ith molecule. The center of gravity of such an instantaneous bolus, (t RO i,), is equivalent to
in which (t,) and (t/) are the first and second moments of a function representing the probability density function of transit times through the ROI. (Details of the derivation are available from the author on request.) The first moment is equivalent to the mean transit time.
Using the relation (t f 13 where SD f is the standard deviation of the transit times, and by asserting that SD f is proportional to {tf) 14 
>
15 such that SD f =k(tf), where k is an unknown constant of proportionality, the solution to (tf} in Equation 5 is found to be
For a noninstantaneous bolus, the time-concentration curve for the ROI is the convolution of the real input time-concentration curve and the hypothetical curve resulting from an instantaneous bolus. The centers of gravity of the two convolved functions can be added to give the center of gravity of the convolution, (t RO i)- 13 Therefore,
where (t^,) is the center of gravity of the input curve for the artery supplying the ROI. If the mixing of contrast with blood is similar for any two peripheral arteries visible on the same CT scan, the time- concentration curves of those two vessels should also be similar, any difference being due to a disparity in the arrival time of the bolus. Therefore, if a correction is made for this disparity, the center of gravity of the time-concentration curve of a peripheral artery, (t PA ), can be substituted for (t^) so that {tRoi>-<tb)=(l-m)x((t R oi)-{tpA» (8) where m is the fraction of (t RO i)-(tp A ) that is due to the difference between the time the bolus arrives at the ROI and the time it arrives at the peripheral artery. Using (l-m)x((t R 0 I )-(t P A )) in place of (tRoi)~(tin) in Equation 7 avoids the difficulty in determining (t^). The rCBF is determined by combining Equations 1, 4, 7, and 8 so that
where n represents the factor [(l-Hct P A )x(l+k 2 )]/ [2x(l-jxHct P A )x(l-m)].
Discussion
The use of CT in the qualitative assessment of morphology is well established, and contrast enhancement is an integral factor in the diagnosis of many neurological diseases. The quantitative analysis of contrast enhancement, and particularly how it relates to rCBF, has not been as well documented, although investigators have considered the approach of using dynamic CT to measure blood flow in the brain and other organs. 16 The theoretical approach we have proposed, in conjunction with a CT technology that permits the acquisition of a number of scans over a relatively short period of time, has the potential of providing quantitative data sufficient to determine rCBF noninvasively. However, there are a number of important factors and limitations that must be considered before this methodology can be properly implemented. The factors include the determination of AUC and (t) for tissue and arterial ROIs and the determination of the peripheral hematocrit (Hct PA ), the proportionality constant relating tissue to peripheral hematocrit (j), the proportionality constant relating the standard deviation in transit times to the mean transit time (k), and the factor accounting for the differences in arrival time between the measured ROI and the artery used for determining (t PA ) (m).
Methods for determining the AUC and (t) based on the fitting of a gamma-variate function to time-concentration data have been described in detail, 17 and it is generally possible to obtain suitable data for ROIs of various sizes. However, in cross-sectional imaging methods such as CT, the use of a small ROI, such as that for a peripheral artery, can introduce errors that can have a major impact in the calculation of rCBF. For instance, the time-concentration data for small, poorly defined vessels may include a substantial portion of the surrounding parenchyma, which could lead to an underestimation of AUCp A . It is essential, therefore, that the arterial ROI be selected carefully and that the vessel selected be large enough to clearly encompass the ROI. Another important consideration in acquiring time-concentration data for an ROI within brain tissue is BBB breakdown, which could tend to increase AUC and (t). However, if the magnitude of the leakiness (i.e., the transfer constant) is small relative to the rCBF, this effect should be minor. If inflow of the contrast into the ROI is completed prior to outflow and if transfer across the BBB is unidirectional during the passage of the bolus, it is possible to test the effects of BBB breakdown on the time-concentration curve. Beyond the peak of the time-concentration curve (when inflow is completed), the change in contrast concentration will be reduced by a fraction equivalent to the fraction of total blood flow that crosses the BBB. Based on such a computation, if the BBB transfer is 5% of total flow, the changes in calculated vascularity, mean transit time, and rCBF are estimated to be only 1.6%, 2.4%, and -0.8%, respectively. Even for BBB transfers as large as 20% of total flow, the changes for the same respective parameters are only 10.2%, 14.2%, and -3.5%.
Because of the form of Equation 1, the accurate determination of mean transit time for rCBF calculation is most critical at short transit times, and underestimations of transit time would tend to result in larger errors than overestimations. For example, whereas a 0.2-second overestimation or underestimation of a mean transit time of 3.0 seconds would result in errors in rCBF of -6.2% and 7.1%, respectively, similar errors for a mean transit time of 1.0 second would result in errors in rCBF of -16.7% and 25%, respectively.
Accurate values for peripheral blood (Hct PA ) and tissue (Hct ROI ) hematocrits are important factors in the calculation of rCBF by CT (Equations 3 and 9) . Although Hct PA can be readily determined from a venous blood sample, the indicator bolus will reduce the hematocrit due to simple dilution. If this effect of dilution is not taken into consideration, some errors could be introduced into the rCBF measurement. For instance, assuming a hematocrit of 40%, a factor of j in humans of 0.75, 18 a bolus of contrast of 1 ml/kg, a bolus width within the brain of 5 seconds, and a cardiac output varying from 35 to 140 ml/kg/min, the uncorrected rCBF could change by 2-8%. It is possible, however, to explicitly determine and correct for this dilution because the volume diluted will be equivalent to the product of total cardiac output during bolus passage (in units of volume per unit time) and the bolus width (in units of time). Both factors can be determined from a time-concentration curve of a peripheral artery. 1 Another factor involved in the computation of rCBF by CT is the proportionality constant k, which relates the variation in transit times through the ROI to the mean transit time. If blood flow in the brain is modeled as a plug of fluid flowing through a single tube, the variation in transit times would be 0 and thus k would be 0. If blood flow through an ROI is modeled as flowing through a single well-mixed compartment, the washout of blood from the region is exponential in form. 17 For such a model, the mean transit (or washout) time is equivalent to the standard deviation of transit times, and thus k would be 1. Attempts to describe blood flow with more sophisticated models such as multiple parallel compartments have resulted in values that are clearly at odds with experimental results, 19 suggesting that the value of k must be determined empirically. The value of k has been shown to be remarkably constant within a given organ system, with values between 0 and 1 depending on the system, 1415 which implies that true blood flow is something between plug flow and flow in a single well-mixed compartment. Although the value of k has not been determined for brain, it could theoretically be determined using dynamic CT. Similar to the calculation of the mean transit time (see Equation 7 and accompanying theory), the standard deviation of transit times can be calculated from the difference in variance of two time-concentration curves acquired for the draining vein and supplying artery for an ROI. 13 Although it may be difficult to find such a vein or artery for a specific ROI, it is generally possible to identify other arteries and veins with time-concentration curves similar to those of the draining vein and supplying artery. For example, on a transverse scan of the dog brain, the vein of the corpus callosum and the lingual artery are generally visible, and these vessels should have time-concentration curves similar to the draining veins and supplying arteries for the level of the brain within the scan plane. A function such as the gamma-variate could be fitted to the time-concentration curves for such vessels and used to derive the variance of the curves, the mean transit time, and the standard deviation of transit times. 19 The magnitude of k could then be derived from the equation k=(av e 2 -Op A 2 ) 1/2 / ((t Ve )-(t PA )), where a is the variance of time-concentration curves for the vein (Ve) of the corpus callosum or the lingual artery (PA) and (t Ve ) is the center of gravity of the venous curve.
The factor m can be determined from the difference in the times of arrival of the contrast indicator at the peripheral artery used for determining (t PA ) and at the ROI in brain tissue. When the peripheral artery and the ROI are within the same scan plane, the arrival times should be similar and m should be relatively small. However, if the difference in arrival times becomes large relative to the mean transit time (i.e., m becomes larger), m would have a greater impact on the rCBF calculation.
The measurement of rCBF is thus possible assuming one can acquire accurate time-concentration data for the ROI and a peripheral artery. The primary advantage of this technique is that it provides a much simpler method than deconvolution for the determination of mean transit time. In addition, it allows for the accurate determination of fractional vascular volume. The method should provide a practical method of rCBF determination using dynamic CT.
